MetaCap

Artivion Financial Ratios

NYSE: AORTHealth CareMedical/Dental InstrumentsUSD

21.26+0.05 (+0.24%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Artivion ratio analysis

Artivion earned a net margin of 2.2% in FY 2025, up from -3.4% a year earlier. Gross margin was 64.4% compared with a median of 65.9% over the prior 9 years. Return on equity reached 2.2%, meaning Artivion generated 0.02 dollars of profit for every dollar of shareholders' equity.

Debt-to-equity stood at 0.48 versus 1.14 the year before, and the current ratio was 3.53. At the end of FY 2025, AORT traded at 211.7 times earnings; across the 4 fiscal years shown, its year-end P/E ranged from 59.8 to 548.0, with a median of 192.9. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Artivion financial ratios (annual)

Artivion annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
P/E ratio (at fiscal year end)211.71—————548.00—174.0959.84
Price / sales4.572.992.061.552.653.533.683.753.333.38
Price / book4.504.212.591.712.642.723.563.582.282.92
Gross margin64.4%64.0%64.7%64.5%66.1%66.3%66.3%65.8%67.8%65.9%
Operating margin7.6%10.0%1.6%2.0%2.7%1.0%6.2%3.5%4.2%12.1%
Net margin2.2%-3.4%-8.7%-6.1%-5.0%-6.6%0.6%-1.1%2.0%6.0%
Free cash flow margin0.2%2.8%2.6%-5.1%-5.2%2.0%2.8%1.6%2.2%7.5%
Return on equity (ROE)2.2%-4.8%-10.9%-6.7%-4.9%-5.1%0.6%-1.0%1.3%5.2%
Return on assets (ROA)1.1%-1.7%-3.9%-2.5%-1.9%-2.1%0.3%-0.5%0.6%3.4%
Debt / equity0.481.141.091.081.030.890.760.790.790.34
Current ratio3.534.344.854.985.513.884.155.194.184.89
Revenue growth13.6%9.8%12.8%5.0%18.0%-8.3%5.1%38.6%5.2%23.6%
EPS growth—————-980.0%—-172.7%-65.6%128.6%

Related